Showing 1 - 8 results of 8 for search 'Hong-wu Chen', query time: 0.05s Refine Results
  1. 1
    Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner

    Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner by Hongye Zou, Yatian Yang, Hong-Wu Chen, Hong-Wu Chen, Hong-Wu Chen

    Published 2023-04-01
    Get full text
    Article
  2. 2
    The integrated bioinformatic analysis identifies immune microenvironment-related potential biomarkers for patients with gestational diabetes mellitus

    The integrated bioinformatic analysis identifies immune microenvironment-related potential biomarkers for patients with gestational diabetes mellitus by Jie-ling Chen, Hui-fang Dai, Xin-chen Kan, Xin-chen Kan, Jie Wu, Jie Wu, Jie Wu, Hong-Wu Chen, Hong-Wu Chen, Hong-Wu Chen

    Published 2024-02-01
    Get full text
    Article
  3. 3
    A master regulator of cholesterol biosynthesis constitutes a therapeutic liability of triple negative breast cancer

    A master regulator of cholesterol biosynthesis constitutes a therapeutic liability of triple negative breast cancer by Demin Cai, Xiong Zhang, Hong-Wu Chen

    Published 2020-03-01
    Get full text
    Article
  4. 4
    Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

    Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer by Yixin Chen, Mei-Juan Tu, Fangwei Han, Zhenzhen Liu, Neelu Batra, Primo N. Lara, Hong-Wu Chen, Huichang Bi, Ai-Ming Yu

    Published 2023-10-01
    Get full text
    Article
  5. 5
    Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment

    Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment by Bo Chen, William J Murphy, Xiong Zhang, Pengfei Xu, Chengfei Liu, Joy C Yang, Christopher Nip, Jonathan E Van Dyke, Hong-Wu Chen, Christopher P Evans

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study)

    Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controll... by Jie Xu, Hao Hu, Dan li, Hong-Wu Chen, Jiawei Wu, Yu-Wei Wang, Likun Ma, Jing-Sheng Hua, Xiang-Yong Kong, Long-Wei Li, Jian-Yuan Pan

    Published 2024-07-01
    Get full text
    Article
  7. 7
    Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer

    Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer by Jia-Luo Huang, Xue-Long Yan, Dong Huang, Lu Gan, Huahua Gao, Run-Zhu Fan, Shen Li, Fang-Yu Yuan, Xinying Zhu, Gui-Hua Tang, Hong-Wu Chen, Junjian Wang, Sheng Yin

    Published 2023-12-01
    Get full text
    Article
  8. 8
    Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer

    Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer by Pengfei Xu, Joy C. Yang, Bo Chen, Shu Ning, Xiong Zhang, Leyi Wang, Christopher Nip, Yuqiu Shen, Oleta T. Johnson, Gabriela Grigorean, Brett Phinney, Liangren Liu, Qiang Wei, Eva Corey, Clifford G. Tepper, Hong-Wu Chen, Christopher P. Evans, Marc A. Dall’Era, Allen C. Gao, Jason E. Gestwicki, Chengfei Liu

    Published 2024-08-01
    Get full text
    Article

Search Tools: